← back to search

Maria Bonsack

German Cancer Research Center · DE
Area of research
Immunology · Molecular Biology
Research interest
Research interests include vaccines and immunoinformatics approaches, Immunotherapy and Immune Responses, Monoclonal and Polyclonal Antibodies Research, and T-cell and B-cell Immunology.
h-index
8
citations
941
works
35
NIH funding
primary concept
email

Recent publications

Definition and Characterization of SOX11-Derived T Cell Epitopes towards Immunotherapy of Glioma
International Journal of Molecular Sciences 2023cited by 10position: middledoi
Effects of hypoxia on antigen presentation and T cell-based immune recognition of HPV16-transformed cells
Frontiers in Immunology 2022cited by 3position: middledoi
The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution
Nature Communications 2020cited by 130position: middledoi
Application of individual HLA-binding prediction thresholds increases the detection of target cell surface-presented HPV16 E6- and E7-derived epitopes as a basis for therapeutic HPV vaccine design
The Journal of Immunology 2020cited by 2position: firstdoi
Abstract A33: High-throughput prediction of MHC Class I and Class II neoantigens with MHCnuggets
Cancer Immunology Research 2020cited by 0position: middledoi
High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggets
Cancer Immunology Research 2019cited by 195position: middledoi
Performance Evaluation of MHC Class-I Binding Prediction Tools Based on an Experimentally Validated MHC–Peptide Binding Data Set
Cancer Immunology Research 2019cited by 89position: firstdoi
The shared <i>neo</i> antigen landscape of MSI cancers reflects immunoediting during tumor evolution
bioRxiv (Cold Spring Harbor Laboratory) 2019cited by 7position: middledoi
High-throughput prediction of MHC Class I and Class II neoantigens with MHCnuggets
bioRxiv (Cold Spring Harbor Laboratory) 2019cited by 5position: middledoi
Abstract 578: Investigation of the effect of hypoxia on presentation of HPV16-derived antigens - implications for therapeutic vaccine design
Immunology 2019cited by 0position: middledoi
Abstract 571: The shared mutation and <i>neo</i>antigen landscape of MMR-deficient colorectal cancers suggests immunoediting during tumor evolution
Cancer Research 2019cited by 0position: middledoi
MHCflurry: Open-Source Class I MHC Binding Affinity Prediction
Cell Systems 2018cited by 426position: middledoi
A Targeted LC‐MS Strategy for Low‐Abundant HLA Class‐I‐Presented Peptide Detection Identifies Novel Human Papillomavirus T‐Cell Epitopes
PROTEOMICS 2018cited by 37position: middledoi
PRAME peptide‐specific CD8<sup>+</sup> T cells represent the predominant response against leukemia‐associated antigens in healthy individuals
European Journal of Immunology 2018cited by 11position: middledoi
Abstract 721: Development of a therapeutic HPV vaccine based on mass spectrometry-verified target epitopes
Cancer Research 2018cited by 0position: middledoi
MHCflurry: open-source class I MHC binding affinity prediction
bioRxiv (Cold Spring Harbor Laboratory) 2017cited by 26position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Angelika B. Riemer · German Cancer Research Center13 papers (2017–2023)Renata Blatnik · Bruker (Germany)5 papers (2018–2020)Nitya Mohan · Institute of Cancer Research5 papers (2018–2022)Stéphanie Hoppe · Institut Bergonié4 papers (2018–2020)Rohit Bhattacharya · Williams College3 papers (2019–2020)Ashton Omdahl · Johns Hopkins Medicine3 papers (2019–2020)Alina Steinbach · Heidelberg University3 papers (2018–2019)Valsamo Anagnostou · Cornell University3 papers (2019–2020)Justin Huang · The First Affiliated Hospital, Sun Yat-sen University3 papers (2019–2020)Jonas D. Förster · German Cancer Research Center3 papers (2019–2022)Collin Tokheim · Johns Hopkins University3 papers (2019–2020)Rachel Karchin · University of Baltimore3 papers (2019–2020)Michael Jendrusch · Heidelberg University2 papers (2019–2019)I.K. Ashok Sivakumar · Johns Hopkins University2 papers (2019–2019)Xiaoshan M. Shao · Johns Hopkins Medicine2 papers (2019–2020)Sonja Krausert · German Cancer Research Center2 papers (2019–2019)Dylan Hirsch · Johns Hopkins Medicine2 papers (2019–2020)Maartje Nielsen · University of Kentucky2 papers (2019–2019)Elisabeth Pfaffendorf · European Molecular Biology Organization2 papers (2019–2019)Lily Zheng · Center for Drug Evaluation and Research2 papers (2019–2020)